For the medicine’s approval history
The published FDA record for sermorelin (Geref) sets out its old uses and approval dates. Those approvals had ended by June 18, 2009; the position was checked on September 28, 2026.
Read FDA as the abbreviation for Food and Drug Administration. When an offer mentions approval, ask for the product name and the named use in the record. Read those beside the offer’s actual wording.
For a claim about a benefit
Ask to see the study behind it. Read what was measured and who took part. Keep a result about a related substance separate from a result about the medicine being offered.
The Khorram adult study, for example, tested a substance closely related to sermorelin. Its chemical make-up had been changed, so it was not sermorelin itself; this research was reviewed on September 28, 2026.
A record is useful within its limits.
For the person or pharmacy
Physician licence status and public disciplinary actions can be read through state medical boards. Even when a record shows no public action, it gives no grade for the care, as the medical boards’ consumer information explains.
A National Drug Code (NDC) lets you find a product’s record in the FDA’s drug directory, a list of drug information. Having that record does not mean FDA checked the submitted details or approved the product, as of September 26, 2026. The FDA’s explanation of drug codes describes that limit.
You can ask for a link and take time to read it. A source name spoken quickly during a sales call does not have to be the end of the conversation.